All Virology articles – Page 4
-
NewsPotential drug takes aim at emerging Chikungunya virus
Researchers are developing what could become the first-ever treatment against the debilitating joint pain that can last months or years after becoming infected with the emerging Chikungunya virus.
-
News New virus discovered in Swiss ticks
Researchers from the Institute of Virology at the University of Zurich (UZH) have detected the Alongshan virus (ALSV) for the first time in ticks in Switzerland.
-
NewsResearchers find new viral entryway into host cells for Covid-19
A University of Ottawa-led team has found a new viral entry for SARS-CoV-2, suggesting it may be able to use proteins to infect a wider range of cells.
-
NewsImmune response discovery solves mystery of why colds are more common when it’s cold
Scientists say a newly discovered immune response inside the nose is suppressed by colder temperatures, offering evidence for why colds, flu and COVID-19 are more common in cooler months.
-
NewsClover’s vaccine candidate reduced household transmission of SARS-CoV-2
A collaboration between Clover Biopharmaceuticals Ltd and the International Vaccine Institute showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebos.
-
NewsCOVID-19 infection disrupts gut microbes, especially with antibiotics
Acute infection disrupts a healthy balance between good and bad microbes in the gut, especially with antibiotic treatment, researchers have found.
-
NewsResearchers develop tailored Covid neutralizer that can adapt to mutations
A research team at Pohang University of Science and Technology has developed a tailored COVID-19 neutralizer that can adapt to all kinds of mutations in the virus in treating the viral infection.
-
NewsNew Omicron subvariant resistant to all approved therapeutic antibodies
Rrsearchers in Germany have found that the Omicron sub-lineage BQ.1.1, currently on the rise worldwide, is resistant to all the approved antibody therapies used to treat individuals at risk for severe Covid-19 disease.
-
NewsHidden Nsp1 cavity means Covid’s Spike protein is no longer the only target
Researchers have revealed the existence of a hidden ’’pocket’ on the surface of the non-structural protein Nsp1 on the surface of the Covid-19 virus which could offer a potential drug target and alternative to the Spike protein targeted by vaccines.
-
NewsHIV infection leaves memory that persists in cells even when virus is gone
A new study explains why people living with HIV may suffer from chronic inflammation, which can put them at an increased risk of developing comorbidities such as cardiovascular disease and neurocognitive dysfunction and how suppression or even eradication of HIV in the body may not resolve it. ...
-
NewsGene-delivering viruses cross into brain in step toward gene therapy for neurological diseases
A family of adeno-associated viruses (AAVs) has been developed that are capable of delivering gene therapies to the brain, a particularly challenging target tissue.
-
NewsCOVID-19 reanimates latent viruses in cells – particularly in ME patients
Researchers have found that COVID-19 reactivates viruses that had become latent in cells following previous infections, particularly in people with chronic fatigue syndrome, also known as ME/CFS.
-
NewsSARS-CoV-2 alters functioning of RNA in infected cells
Researchers have shown that infection by SARS-CoV-2, the virus that causes COVID-19, changes the functioning of host cell RNA.
-
OpinionEngineering viruses to make the world a more dangerous place
Virologists should think thrice before embarking on gain of function experiments
-
NewsCoffee compound could offer protection from catching COVID-19
Researchers have shown that a compound found in coffee could help to protect against infection by Covid-19.
-
NewsMonkeypox mutations cause virus to spread rapidly and dodge vaccines
Researchers at the University of Missouri have identified the specific mutations in the monkeypox virus that contribute to its continued infectiousness.
-
NewsNew monkeypox study increases fear of potential escalation in central Africa
A new study of monkeypox infections in a remote area of the Democratic Republic of the Congo (DRC) shows transmission rates rising closer to the point where outbreaks are likely to be larger and more frequent.
-
NewsCOVID-19 virus increases risk of other infections by disrupting normal mix of gut bacteria
Infection with Covid-19 can reduce the number of bacterial species in a patient’s gut, with the lesser diversity creating space for dangerous microbes to thrive, a new study has found.
-
NewsExperimental monoclonal antibodies take the fight to Epstein-Barr virus
Researchers have discovered a panel of investigational monoclonal antibodies (mAbs) targeting different sites of the Epstein-Barr virus (EBV) blocked infection when tested in human cells in a laboratory setting.
-
NewsResearchers find SARS-CoV-2 Omicron BA.2 subvariant less severe than earlier variants
team led by investigators at Massachusetts General Hospital (MGH) has determined that the SARS-CoV-2 Omicron BA.2 subvariant is less severe than the previous Delta variant and less severe to an even greater extent than the original Omicron variant.